Results 191 to 200 of about 100,395 (290)

Polycystic Ovary Syndrome Revisited: Novel Insights and Updates. [PDF]

Int J Med Sci
Zhao W, Zhou J, Song Y, He M, Zhu X, Yu B, Gao W.   +6 more
europepmc   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld, Nicole Kasatkin, Bi Liu Yu, Milen Velinov, Justin S. Brandt, Elena Ashkinadze   +5 more
wiley   +1 more source

Activation and DNA methylation of PANoptosis in polycystic ovary syndrome. [PDF]

PLoS One
Han Y, Han Y, Feng Y, Shan Y, Liu C, Wang K, Li X, Zhang S, Zhu X.   +8 more
europepmc   +1 more source

First‐trimester preexisting diabetes screening in Medicaid beneficiaries

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Introduction Patients with public insurance have higher rates of pregestational diabetes mellitus (DM) and are less likely to receive preconception care than those with private insurance. First trimester DM screening rates among high‐risk publicly insured pregnant individuals in the United States are unknown.
Zeinab Kassem, Sebastian Z. Ramos, Benjamin Koethe, Mohak Mhatre   +3 more
wiley   +1 more source

Biographical Discovery, Affirmation, and Disruption: Trans and Nonbinary Peoples' Experiences Negotiating Gender and Polycystic Ovary Syndrome

Sociology of Health &Illness, Volume 48, Issue 4, May 2026.
ABSTRACT Polycystic ovary syndrome (PCOS) is the most common endocrine irregularity in people who are assigned‐female‐at‐birth and are of reproductive age. PCOS causes infertility, irregular periods and hirsutism. Cis women with PCOS describe these symptoms as ‘masculinising,’ which makes them feel inauthentic as women.
Annie McGhee, Ashlyn Arthur
wiley   +1 more source

Micronutrients in polycystic ovary syndrome: molecular pathways, deficiencies, and therapeutic potential. [PDF]

Front Endocrinol (Lausanne)
Natarajan M, E SH, Nataraj R.
europepmc   +1 more source

Kisspeptin as a test of hypothalamic dysfunction in pubertal and reproductive disorders

Andrology, Volume 14, Issue 4, Page 1002-1016, May 2026.
Abstract The hypothalamic–pituitary–gonadal axis is regulated by the gonadotropin‐releasing hormone pulse generator in the hypothalamus. This is comprised of neurons that secrete kisspeptin in a pulsatile manner to stimulate the release of GnRH, and, in turn, downstream gonadotropins from the pituitary gland, and subsequently sex steroids and ...
Aureliane C. S. Pierret, Aaran H. Patel, Elisabeth Daniels, Alexander N. Comninos, Waljit S. Dhillo, Ali Abbara   +5 more
wiley   +1 more source

Beyond Metformin: A Review of Non-pharmacological Treatments for Polycystic Ovary Syndrome. [PDF]

Cureus
Lakshmi PI, Kj S, Shetty P.
europepmc   +1 more source

Association between history of fertility problems and pregnancy and birth complications: A longitudinal population‐based cohort study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 5, Page 859-867, May 2026.
In this large cohort of women in Australia, a history of fertility problems was not independently associated with adverse pregnancy outcomes after adjustment. Observed risks were more likely attributable to shared underlying maternal health and lifestyle factors.
Cathryn A. Tully, Danielle Schoenaker, Leanne Pacella‐Ince, Allison M. Hodge, Jessica A. Grieger   +4 more
wiley   +1 more source

Women with PCOS have a later menopausal transition and a lower prevalence of menopausal symptoms at age 46: A population‐based birth cohort study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 5, Page 836-846, May 2026.
Findings from a population‐based cohort study indicate that late peri−/postmenopausal status, as well as menopausal symptoms, were less prevalent in women with PCOS at age 46, supporting the hypothesis of prolonged ovarian function and a delayed menopausal transition with this condition. Created in https://BioRender.com.
Johanna Lavi, Susanna Savukoski, Elisa Hurskainen, Meri‐Maija Ollila, Laure Morin‐Papunen, Maarit Niinimäki, Terhi T. Piltonen   +6 more
wiley   +1 more source